XPO1 is involved in the export of many critical cellular regulators, making XPO1 inhibition a broadly relevant therapeutic strategy, yet the exact mechanisms of action of XPO1 inhibition may be unique to different cancer subtypes and specific mutations. The gene discussed is XPO1; the disease is cancer.